NASDAQ 100
21.08.2008 11:00:00
|
Patterson Companies Reports Improved First Quarter Sales and Earnings Per Share
Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated
sales of $743,859,000 for the first quarter of fiscal 2009 ended July
26, an increase of 6% from $701,403,000 in the year-earlier quarter.
Earnings per diluted share of $0.39 were up 11% from $0.35 in the
year-earlier quarter.
Sales of Patterson Dental, Patterson’s largest
business, increased 4% to $519,885,000 in the first quarter.
Sales of consumable dental supplies and printed office products rose
6% during this period.
Sales of dental equipment and software were down 2% from the first
quarter of fiscal 2008. Basic dental equipment sales, including
chairs, units and lighting, increased 4% from the year-earlier level.
Sales of other services and products, consisting primarily of
technical service, parts and labor, software support services,
artificial teeth, increased 10% in the first quarter.
Sales of the Webster Veterinary unit increased 12% in the first quarter
of fiscal 2009 to $123,274,000. Sales of Patterson Medical, Patterson’s
rehabilitation supply and equipment unit, increased 10% to $100,700,000
in comparison to the year-earlier level. Excluding the impact of
acquisitions during the past year related to this unit’s
branch office strategy and foreign currency translations, first quarter
sales of Patterson Medical rose over 6%.
Net income of $45,964,000 in this year’s first
quarter was reduced by an additional $6.7 million ($4.2 million net of
tax) of interest expense associated with the $525 million of new
long-term debt financing that was completed in last year’s
fourth quarter. Patterson used the proceeds of the debt issuance and
cash to repurchase 19 million shares of its common stock during the
second half of fiscal 2008. Net income was $47,544,000 in the
year-earlier quarter.
James W. Wiltz, president and chief executive officer, commented: "First
quarter sales of our Patterson Dental unit were largely consistent with
our internal forecasts for this period. Sales of consumable supplies and
basic dental equipment posted solid sales growth. As anticipated, sales
of software and digital x-ray systems were adversely affected by the
roll-out of our previously announced sales and marketing initiatives
that are changing many of the ways we do business. The commission
structure of Patterson Dental’s sales force
was revamped to better align compensation with the growth objectives and
strategies of the organization. In addition, we started offering our
EagleSoft® practice management software free
of charge to any dentist with the goal of winning new customers for our
digital x-ray solution, as well as growing revenues from our software
support and e-business services and increasing sales of other equipment
and consumable supplies. The responsibility for selling our digital
solutions was refocused on our territory representatives and equipment
specialists. Our customer loyalty program, now called Patterson
Advantage, has been redesigned to give customers a strong incentive to
partner with us for meeting all of their dental office needs. Finally,
the selection and training of field sales representatives has been
strengthened. By further strengthening Patterson Dental’s
position as the leader and innovator in the North American dental
market, these initiatives are expected to generate improving operating
results in the future.”
He continued: "Patterson’s
veterinary business benefited from the robust growth of its consumables
business in the first quarter. We also are encouraged by Patterson
Medical’s solid first quarter sales growth,
reflecting the unit’s continued progress at
further strengthening its value-added business platform. Sales of
rehabilitation equipment were particularly strong in the first quarter,
due partly to the addition of the industry-leading equipment lines
manufactured by Chattanooga Medical Supply, Inc. Patterson Medical’s
performance also benefited from strong sales posted by its sports
medicine business.”
Patterson is forecasting earnings of $0.45 to $0.47 per diluted share
for the second quarter of fiscal 2009 ending October 25, 2008. The
company also reiterated its previously-issued guidance of $1.94 to $1.98
per diluted share for the full fiscal year.
About Patterson Companies, Inc.
Patterson Companies, Inc. is a value-added distributor serving the
dental, companion-pet veterinarian and rehabilitation supply markets.
Dental Market
As Patterson’s largest business, Patterson
Dental provides a virtually complete range of consumable dental
products, equipment and software, turnkey digital solutions and
value-added services to dentists and dental laboratories throughout
North America.
Veterinary Market
Webster Veterinary is the nation’s second
largest distributor of consumable veterinary supplies, equipment and
software, diagnostic products, vaccines and pharmaceuticals to
companion-pet veterinary clinics.
Rehabilitation Market
Patterson Medical is the world’s leading
distributor of rehabilitation supplies and non-wheelchair assistive
patient products to the physical and occupational therapy markets. The
unit’s global customer base includes
hospitals, long-term care facilities, clinics and dealers.
This release contains forward-looking statements as defined in the
Private Securities Litigation Reform Act of 1995. Forward-looking
statements are information of a non-historical nature and are subject to
risks and uncertainties that are beyond the Company’s
ability to control. The Company cautions shareholders and prospective
investors that the following factors, among others, may cause actual
results to differ materially from those indicated by the forward-looking
statements: competition within the dental, veterinary, and
rehabilitative and assistive living supply industries; changes in the
economics of dentistry, including reduced growth in expenditures by
private dental insurance plans, the effects of economic conditions and
the effects of healthcare reform, which may affect future per capita
expenditures for dental services and the ability and willingness of
dentists to invest in high-technology products; the effects of
healthcare related legislation and regulation which may affect
expenditures or reimbursements for rehabilitative and assistive
products; changes in the economics of the veterinary supply market,
including reduced growth in per capita expenditures for veterinary
services and reduced growth in the number of households owning pets; the
ability of the Company to maintain satisfactory relationships with its
sales force; unexpected loss of key senior management personnel;
unforeseen operating risks; risks associated with the dependence on
manufacturers of the Company’s products; and
the ability of the Company to successfully integrate the recent
acquisitions into its existing business. Forward-looking statements are
qualified in their entirety by the cautionary language set forth in the
Company's filings with the Securities and Exchange Commission.
First Quarter Conference Call and Replay
Patterson's first quarter earnings conference call will start at
10:00 a.m. Eastern today. Investors can listen to a live webcast
of the conference call at www.pattersoncompanies.com.
Listeners should go to this website at least 15 minutes prior to
the call to download and install any necessary audio software. The
conference call will be archived on Patterson's web site. A replay
of the first quarter conference call can be heard through August
28 by dialing 1-303-590-3000 and providing the 11118358
confirmation code.
Institutional Investor Conference Scheduled for September 11,
2008
Where: Waldorf Astoria Hotel, 301 Park Avenue, New York
What: Presentations by Patterson's senior management team
To register for attendance:
Web: http://208.42.82.125/PDCO/NewYorkReg2008.htm
Phone: Equity Market Partners at 904-261-8232
PATTERSON COMPANIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (In thousands, except for earnings per share) (Unaudited)
Three Months Ended
July 26, July 28, 2008 2007
Net sales
$
743,859
$
701,403
Gross profit
251,730
237,134
Operating expenses
172,136
161,927
Operating income
79,594
75,207
Other (expense) income, net
(5,912
)
605
Income before taxes
73,682
75,812
Income taxes
27,718
28,268
Net income
$
45,964
$
47,544
Earnings per share:
Basic
$
0.39
$
0.35
Diluted
$
0.39
$
0.35
Shares:
Basic
117,890
135,785
Diluted
118,712
136,745
Gross margin
33.8
%
33.8
%
Operating expenses as a % of net sales
23.1
%
23.1
%
Operating income as a % of net sales
10.7
%
10.7
%
Effective tax rate
37.6
%
37.3
%
PATTERSON COMPANIES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Dollars in thousands)
July 26, April 26, 2008 2008 (Unaudited) ASSETS
Current assets:
Cash and short-term investments
$
331,150
$
308,164
Receivables, net
348,954
364,050
Inventory
319,220
281,238
Prepaid expenses and other current assets
33,433
31,589
Total current assets
1,032,757
985,041
Property and equipment, net
155,446
148,932
Goodwill and other intangible assets
880,825
881,750
Other
56,765
60,650
Total Assets
$
2,125,793
$
2,076,373
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable
$
183,644
$
194,405
Other accrued liabilities
151,480
141,652
Current maturities of long-term debt
130,008
130,010
Total current liabilities
465,132
466,067
Long-term debt
525,024
525,024
Other non-current liabilities
80,891
80,495
Total liabilities
1,071,047
1,071,586
Stockholders' equity
1,054,746
1,004,787
Total Liabilities and Stockholders' Equity
$
2,125,793
$
2,076,373
PATTERSON COMPANIES, INC. SUPPLEMENTARY FINANCIAL DATA (Dollars in thousands) (Unaudited)
Three Months Ended July 26, July 28, 2008 2007
Consolidated Net Sales
Consumable and printed products
$
498,183
$
464,730
Equipment and software
181,292
179,596
Other
64,384
57,077
Total
$
743,859
$
701,403
Dental Supply
Consumable and printed products
$
312,593
$
295,407
Equipment and software
150,365
152,733
Other
56,927
51,587
Total
$
519,885
$
499,727
Rehabilitation Supply
Consumable and printed products
$
70,373
$
66,322
Equipment and software
24,793
21,175
Other
5,534
3,765
Total
$
100,700
$
91,262
Veterinary Supply
Consumable and printed products
$
115,217
$
103,001
Equipment and software
6,134
5,688
Other
1,923
1,725
Total
$
123,274
$
110,414
Other (Expense) Income, net
Interest income
$
1,922
$
2,348
Interest expense
(8,052
)
(2,497
)
Other
218
754
$
(5,912
)
$
605
Note: Certain amounts previously reported have been reclassified to
conform with the current presentation.
PATTERSON COMPANIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Dollars in thousands) (Unaudited)
Three Months Ended July 26, July 28, 2008 2007
Operating activities:
Net income
$
45,964
$
47,544
Depreciation & amortization
6,383
6,083
Stock-based compensation
1,962
1,969
Change in assets and liabilities, net of acquired
(21,713
)
(2,456
)
Net cash provided by operating activities
32,596
53,140
Investing activities:
Additions to property and equipment, net
(11,479
)
(5,007
)
Acquisitions
(513
)
(2,828
)
Net cash used in investing activities
(11,992
)
(7,835
)
Net cash provided by financing activities
2,407
3,727
Effect of exchange rate changes on cash
(25
)
3,409
Net increase in cash and cash equivalents
$
22,986
$
52,441
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Indizes in diesem Artikel
NASDAQ Comp. | 19 218,17 | 0,83% | |
NASDAQ 100 | 20 930,37 | 0,90% | |
S&P 400 MidCap | 1 854,40 | -0,45% |